Published in Gene Therapy Weekly, October 5th, 1998
"Both of these features are critically important to molecular biology researchers," said T. Christian Boles, Ph.D., Mosaic Technologies.
Acrydite, a proprietary molecule designed and developed by Mosaic Technologies for DNA immobilization and hybridization, is now being marketed to some 80,000 "bench scientists" across the United States, Canada, Mexico and Europe. Details of "Mutation Typing Using Electrophoresis...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.